Models of circumstellar molecular radio line emission: Mass loss rates for a sample of bright carbon stars [PDF]
F. L. Schoeier, H. Olofsson
openalex +1 more source
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
Comparative Wear Evaluation of Pure Zn, Zn-Mg and Zn-Mg-Y Alloys Using Mass Loss Measurements and Optical Profilometry. [PDF]
Severin TL +10 more
europepmc +1 more source
Fractal Characterization of the Mass Loss of Bronze by Erosion-Corrosion in Seawater. [PDF]
Bărbulescu A.
europepmc +1 more source
Invariant Mass Loss as a Source of Dark Energy: A Novel Dynamical Mechanism for Cosmic Acceleration
Benedetto Di Vico
openalex +1 more source
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source
Body Composition Changes After Bariatric Surgery: Magnitude, Timing, and Determinants of Excessive Fat-Free Mass Loss. [PDF]
Perez-Romero N +7 more
europepmc +1 more source
Can artificial intelligence simplify the screening of muscle mass loss? [PDF]
Buccheri E +5 more
europepmc +1 more source
Optimization of a Brayton-Joule Engine Subject to Mass Transfer Limitations Due to Pressure Losses [PDF]
Michel Feidt +2 more
openalex +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source

